Effects of intraamygdaloid microinjections of acylated-ghrelin on liquid food intake of rats

Krisztián Tóth, Kristóf László, Éva Eszter Bagi, Edit Lukács, L. Lénárd

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Ghrelin (Ghr) has two main forms in the blood: the acylated (A-Ghr) and non-acylated (NA-Ghr) Ghr. A-Ghr was discovered as a potent growth hormone (GH) secretion increasing substance acting on GH secretagouge receptor (GHS-R) type 1a. A-Ghr facilitates food intake after its i.p., i.c.v. or direct hypothalamic application. Immunohistological assays identified projections of ghrelinergic neurons to the basolateral nucleus (ABL) of the amygdala (AMY). A-Ghr injected into the hypothalamus caused c-Fos overexpression in the AMY area that has an important role in food intake and body weight regulation. In separate experiments, liquid food intake of male wistar rats was measured after bilateral intraamygdalar or bilateral i.c.v. administration of A-Ghr (25, 50, 100, 250, and 500 ng/side or 500 and 1000 ng/side, A-Ghr dissolved in 0.15 M sterile NaCl/0.4 μl or 1 μl, respectively). In the ABL, A-Ghr microinjections in the 50-250 ng dose range resulted in significant decrease of food intake. The 25 and 500 ng had no effect. Action of 50 ng (14.83 pmol) or 100 ng (30.16 pmol) A-Ghr was eliminated by 15 ng (16.13 pmol) or 30 ng (32.25 pmol) GHS-R antagonist (d-Lys3-GHRP-6) pretreatment. The administration of 30 ng d-Lys3-GHRP-6 in itself had no influence on feeding. I.c.v. applied 1000 ng A-Ghr increased liquid food intake. Our results are the first ones reporting that A-Ghr injected into the ABL resulted in a decrease of liquid food consumption, within a limited dose range. This is a receptor-linked effect because it was eliminated by a GHS-R specific antagonist.

Original languageEnglish
Pages (from-to)105-111
Number of pages7
JournalBrain Research Bulletin
Volume77
Issue number2-3
DOIs
Publication statusPublished - Sep 30 2008

Fingerprint

Ghrelin
Microinjections
Eating
Amygdala
Somatotropin Receptors
Growth Hormone
Hypothalamus
Wistar Rats

Keywords

  • Amygdaloid body
  • Antagonist
  • Ghrelin
  • Liquid food

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effects of intraamygdaloid microinjections of acylated-ghrelin on liquid food intake of rats. / Tóth, Krisztián; László, Kristóf; Bagi, Éva Eszter; Lukács, Edit; Lénárd, L.

In: Brain Research Bulletin, Vol. 77, No. 2-3, 30.09.2008, p. 105-111.

Research output: Contribution to journalArticle

Tóth, Krisztián ; László, Kristóf ; Bagi, Éva Eszter ; Lukács, Edit ; Lénárd, L. / Effects of intraamygdaloid microinjections of acylated-ghrelin on liquid food intake of rats. In: Brain Research Bulletin. 2008 ; Vol. 77, No. 2-3. pp. 105-111.
@article{6b7d41d98dc44412b06b978fb0973035,
title = "Effects of intraamygdaloid microinjections of acylated-ghrelin on liquid food intake of rats",
abstract = "Ghrelin (Ghr) has two main forms in the blood: the acylated (A-Ghr) and non-acylated (NA-Ghr) Ghr. A-Ghr was discovered as a potent growth hormone (GH) secretion increasing substance acting on GH secretagouge receptor (GHS-R) type 1a. A-Ghr facilitates food intake after its i.p., i.c.v. or direct hypothalamic application. Immunohistological assays identified projections of ghrelinergic neurons to the basolateral nucleus (ABL) of the amygdala (AMY). A-Ghr injected into the hypothalamus caused c-Fos overexpression in the AMY area that has an important role in food intake and body weight regulation. In separate experiments, liquid food intake of male wistar rats was measured after bilateral intraamygdalar or bilateral i.c.v. administration of A-Ghr (25, 50, 100, 250, and 500 ng/side or 500 and 1000 ng/side, A-Ghr dissolved in 0.15 M sterile NaCl/0.4 μl or 1 μl, respectively). In the ABL, A-Ghr microinjections in the 50-250 ng dose range resulted in significant decrease of food intake. The 25 and 500 ng had no effect. Action of 50 ng (14.83 pmol) or 100 ng (30.16 pmol) A-Ghr was eliminated by 15 ng (16.13 pmol) or 30 ng (32.25 pmol) GHS-R antagonist (d-Lys3-GHRP-6) pretreatment. The administration of 30 ng d-Lys3-GHRP-6 in itself had no influence on feeding. I.c.v. applied 1000 ng A-Ghr increased liquid food intake. Our results are the first ones reporting that A-Ghr injected into the ABL resulted in a decrease of liquid food consumption, within a limited dose range. This is a receptor-linked effect because it was eliminated by a GHS-R specific antagonist.",
keywords = "Amygdaloid body, Antagonist, Ghrelin, Liquid food",
author = "Kriszti{\'a}n T{\'o}th and Krist{\'o}f L{\'a}szl{\'o} and Bagi, {{\'E}va Eszter} and Edit Luk{\'a}cs and L. L{\'e}n{\'a}rd",
year = "2008",
month = "9",
day = "30",
doi = "10.1016/j.brainresbull.2008.06.008",
language = "English",
volume = "77",
pages = "105--111",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "2-3",

}

TY - JOUR

T1 - Effects of intraamygdaloid microinjections of acylated-ghrelin on liquid food intake of rats

AU - Tóth, Krisztián

AU - László, Kristóf

AU - Bagi, Éva Eszter

AU - Lukács, Edit

AU - Lénárd, L.

PY - 2008/9/30

Y1 - 2008/9/30

N2 - Ghrelin (Ghr) has two main forms in the blood: the acylated (A-Ghr) and non-acylated (NA-Ghr) Ghr. A-Ghr was discovered as a potent growth hormone (GH) secretion increasing substance acting on GH secretagouge receptor (GHS-R) type 1a. A-Ghr facilitates food intake after its i.p., i.c.v. or direct hypothalamic application. Immunohistological assays identified projections of ghrelinergic neurons to the basolateral nucleus (ABL) of the amygdala (AMY). A-Ghr injected into the hypothalamus caused c-Fos overexpression in the AMY area that has an important role in food intake and body weight regulation. In separate experiments, liquid food intake of male wistar rats was measured after bilateral intraamygdalar or bilateral i.c.v. administration of A-Ghr (25, 50, 100, 250, and 500 ng/side or 500 and 1000 ng/side, A-Ghr dissolved in 0.15 M sterile NaCl/0.4 μl or 1 μl, respectively). In the ABL, A-Ghr microinjections in the 50-250 ng dose range resulted in significant decrease of food intake. The 25 and 500 ng had no effect. Action of 50 ng (14.83 pmol) or 100 ng (30.16 pmol) A-Ghr was eliminated by 15 ng (16.13 pmol) or 30 ng (32.25 pmol) GHS-R antagonist (d-Lys3-GHRP-6) pretreatment. The administration of 30 ng d-Lys3-GHRP-6 in itself had no influence on feeding. I.c.v. applied 1000 ng A-Ghr increased liquid food intake. Our results are the first ones reporting that A-Ghr injected into the ABL resulted in a decrease of liquid food consumption, within a limited dose range. This is a receptor-linked effect because it was eliminated by a GHS-R specific antagonist.

AB - Ghrelin (Ghr) has two main forms in the blood: the acylated (A-Ghr) and non-acylated (NA-Ghr) Ghr. A-Ghr was discovered as a potent growth hormone (GH) secretion increasing substance acting on GH secretagouge receptor (GHS-R) type 1a. A-Ghr facilitates food intake after its i.p., i.c.v. or direct hypothalamic application. Immunohistological assays identified projections of ghrelinergic neurons to the basolateral nucleus (ABL) of the amygdala (AMY). A-Ghr injected into the hypothalamus caused c-Fos overexpression in the AMY area that has an important role in food intake and body weight regulation. In separate experiments, liquid food intake of male wistar rats was measured after bilateral intraamygdalar or bilateral i.c.v. administration of A-Ghr (25, 50, 100, 250, and 500 ng/side or 500 and 1000 ng/side, A-Ghr dissolved in 0.15 M sterile NaCl/0.4 μl or 1 μl, respectively). In the ABL, A-Ghr microinjections in the 50-250 ng dose range resulted in significant decrease of food intake. The 25 and 500 ng had no effect. Action of 50 ng (14.83 pmol) or 100 ng (30.16 pmol) A-Ghr was eliminated by 15 ng (16.13 pmol) or 30 ng (32.25 pmol) GHS-R antagonist (d-Lys3-GHRP-6) pretreatment. The administration of 30 ng d-Lys3-GHRP-6 in itself had no influence on feeding. I.c.v. applied 1000 ng A-Ghr increased liquid food intake. Our results are the first ones reporting that A-Ghr injected into the ABL resulted in a decrease of liquid food consumption, within a limited dose range. This is a receptor-linked effect because it was eliminated by a GHS-R specific antagonist.

KW - Amygdaloid body

KW - Antagonist

KW - Ghrelin

KW - Liquid food

UR - http://www.scopus.com/inward/record.url?scp=51749111061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749111061&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2008.06.008

DO - 10.1016/j.brainresbull.2008.06.008

M3 - Article

VL - 77

SP - 105

EP - 111

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 2-3

ER -